S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   191.69 (-0.96%)
AAPL   236.41 (+0.48%)
FB   185.85 (-2.38%)
MSFT   137.41 (-1.63%)
GOOGL   1,244.41 (-0.67%)
AMZN   1,757.51 (-1.68%)
CGC   20.21 (-2.65%)
NVDA   190.49 (-1.96%)
MU   43.47 (-4.46%)
BABA   169.13 (-4.37%)
GE   8.96 (-0.88%)
TSLA   256.95 (-1.92%)
AMD   30.97 (-0.55%)
T   38.47 (+1.75%)
F   9.29 (+1.98%)
ACB   3.68 (-5.40%)
PRI   123.53 (-0.44%)
NFLX   275.30 (-6.15%)
BAC   30.35 (+0.30%)
GILD   64.91 (-0.49%)
DIS   130.89 (-1.12%)
S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   191.69 (-0.96%)
AAPL   236.41 (+0.48%)
FB   185.85 (-2.38%)
MSFT   137.41 (-1.63%)
GOOGL   1,244.41 (-0.67%)
AMZN   1,757.51 (-1.68%)
CGC   20.21 (-2.65%)
NVDA   190.49 (-1.96%)
MU   43.47 (-4.46%)
BABA   169.13 (-4.37%)
GE   8.96 (-0.88%)
TSLA   256.95 (-1.92%)
AMD   30.97 (-0.55%)
T   38.47 (+1.75%)
F   9.29 (+1.98%)
ACB   3.68 (-5.40%)
PRI   123.53 (-0.44%)
NFLX   275.30 (-6.15%)
BAC   30.35 (+0.30%)
GILD   64.91 (-0.49%)
DIS   130.89 (-1.12%)
Log in

Accuray Stock Price, News & Analysis (NASDAQ:ARAY)

$2.66
+0.10 (+3.91 %)
(As of 10/18/2019 04:00 PM ET)
Today's Range
$2.53
Now: $2.66
$2.69
50-Day Range
$2.55
MA: $2.81
$3.15
52-Week Range
$2.35
Now: $2.66
$5.40
Volume383,865 shs
Average Volume711,147 shs
Market Capitalization$236.16 million
P/E RatioN/A
Dividend YieldN/A
Beta1.94
Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body. The company offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body. The CyberKnife System automatically tracks, detects, and corrects for tumor and patient movement in real-time during the procedure, as well as enables the delivery of precise, high dose radiation while patients breathe normally. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:ARAY
CUSIP00439710
Phone408-716-4600

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$418.79 million
Book Value$0.57 per share

Profitability

Net Income$-16,430,000.00

Miscellaneous

Employees998
Market Cap$236.16 million
Next Earnings Date10/29/2019 (Confirmed)
OptionableOptionable

Receive ARAY News and Ratings via Email

Sign-up to receive the latest news and ratings for ARAY and its competitors with MarketBeat's FREE daily newsletter.


Accuray (NASDAQ:ARAY) Frequently Asked Questions

What is Accuray's stock symbol?

Accuray trades on the NASDAQ under the ticker symbol "ARAY."

How were Accuray's earnings last quarter?

Accuray Incorporated (NASDAQ:ARAY) announced its earnings results on Thursday, August, 15th. The medical equipment provider reported ($0.02) EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.03 by $0.05. The medical equipment provider earned $117.42 million during the quarter, compared to analysts' expectations of $116.09 million. Accuray had a negative net margin of 3.92% and a negative return on equity of 26.69%. During the same quarter in the prior year, the company earned ($0.01) EPS. View Accuray's Earnings History.

When is Accuray's next earnings date?

Accuray is scheduled to release their next quarterly earnings announcement on Tuesday, October 29th 2019. View Earnings Estimates for Accuray.

How can I listen to Accuray's earnings call?

Accuray will be holding an earnings conference call on Tuesday, October 29th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What guidance has Accuray issued on next quarter's earnings?

Accuray issued an update on its FY 2020 earnings guidance on Thursday, August, 15th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $410-420 million, compared to the consensus revenue estimate of $436.86 million.

What price target have analysts set for ARAY?

3 brokers have issued 1 year price targets for Accuray's stock. Their predictions range from $3.90 to $4.00. On average, they expect Accuray's stock price to reach $3.95 in the next twelve months. This suggests a possible upside of 48.5% from the stock's current price. View Analyst Price Targets for Accuray.

What is the consensus analysts' recommendation for Accuray?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Accuray in the last year. There are currently 3 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Accuray.

Has Accuray been receiving favorable news coverage?

News articles about ARAY stock have been trending negative this week, according to InfoTrie. InfoTrie identifies positive and negative media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Accuray earned a news sentiment score of -2.0 on InfoTrie's scale. They also assigned headlines about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for Accuray.

Are investors shorting Accuray?

Accuray saw a decline in short interest during the month of September. As of September 30th, there was short interest totalling 1,920,000 shares, a decline of 21.3% from the August 30th total of 2,440,000 shares. Based on an average daily volume of 588,200 shares, the short-interest ratio is currently 3.3 days. Currently, 2.2% of the company's stock are short sold. View Accuray's Current Options Chain.

Who are some of Accuray's key competitors?

What other stocks do shareholders of Accuray own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Accuray investors own include NVIDIA (NVDA), Activision Blizzard (ATVI), Intel (INTC), Advanced Micro Devices (AMD), Tesla (TSLA), Exelixis (EXEL), FireEye (FEYE), Netflix (NFLX), AK Steel (AKS) and AVEO Pharmaceuticals (AVEO).

Who are Accuray's key executives?

Accuray's management team includes the folowing people:
  • Mr. Joshua H. Levine, Pres, CEO & Director (Age 61)
  • Mr. Andrew Kirkpatrick, Sr. VP & COO (Age 56)
  • Mr. Lionel Hadjadjeba, Sr. VP & Chief Customer Experience Officer (Age 60)
  • Mr. Shigeyuki Hamamatsu, Sr. VP & CFO (Age 46)
  • Mr. Patrick R. Spine, Sr. VP & Chief Admin. Officer

Who are Accuray's major shareholders?

Accuray's stock is owned by a number of of institutional and retail investors. Top institutional investors include Meeder Asset Management Inc. (0.03%). Company insiders that own Accuray stock include Alaleh Nouri, Andrew J Kirkpatrick, Jesse Chew, Joseph E Whitters, Joshua Levine, Kevin Waters, Patrick Spine and Shigeyuki Hamamatsu. View Institutional Ownership Trends for Accuray.

Which major investors are buying Accuray stock?

ARAY stock was bought by a variety of institutional investors in the last quarter, including Meeder Asset Management Inc.. Company insiders that have bought Accuray stock in the last two years include Joseph E Whitters and Joshua Levine. View Insider Buying and Selling for Accuray.

How do I buy shares of Accuray?

Shares of ARAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Accuray's stock price today?

One share of ARAY stock can currently be purchased for approximately $2.66.

How big of a company is Accuray?

Accuray has a market capitalization of $236.16 million and generates $418.79 million in revenue each year. The medical equipment provider earns $-16,430,000.00 in net income (profit) each year or ($0.15) on an earnings per share basis. Accuray employs 998 workers across the globe.View Additional Information About Accuray.

What is Accuray's official website?

The official website for Accuray is http://www.accuray.com/.

How can I contact Accuray?

Accuray's mailing address is 1310 CHESAPEAKE TERRACE, SUNNYVALE CA, 94089. The medical equipment provider can be reached via phone at 408-716-4600 or via email at m[email protected]


MarketBeat Community Rating for Accuray (NASDAQ ARAY)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  301 (Vote Outperform)
Underperform Votes:  277 (Vote Underperform)
Total Votes:  578
MarketBeat's community ratings are surveys of what our community members think about Accuray and other stocks. Vote "Outperform" if you believe ARAY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ARAY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel